» Articles » PMID: 36422472

Dilated Cardiomyopathy Mutation E525K in Human Beta-cardiac Myosin Stabilizes the Interacting-heads Motif and Super-relaxed State of Myosin

Overview
Journal Elife
Specialty Biology
Date 2022 Nov 24
PMID 36422472
Authors
Affiliations
Soon will be listed here.
Abstract

The auto-inhibited, super-relaxed (SRX) state of cardiac myosin is thought to be crucial for regulating contraction, relaxation, and energy conservation in the heart. We used single ATP turnover experiments to demonstrate that a dilated cardiomyopathy (DCM) mutation (E525K) in human beta-cardiac myosin increases the fraction of myosin heads in the SRX state (with slow ATP turnover), especially in physiological ionic strength conditions. We also utilized FRET between a C-terminal GFP tag on the myosin tail and Cy3ATP bound to the active site of the motor domain to estimate the fraction of heads in the closed, interacting-heads motif (IHM); we found a strong correlation between the IHM and SRX state. Negative stain electron microscopy and 2D class averaging of the construct demonstrated that the E525K mutation increased the fraction of molecules adopting the IHM. Overall, our results demonstrate that the E525K DCM mutation may reduce muscle force and power by stabilizing the auto-inhibited SRX state. Our studies also provide direct evidence for a correlation between the SRX biochemical state and the IHM structural state in cardiac muscle myosin. Furthermore, the E525 residue may be implicated in crucial electrostatic interactions that modulate this conserved, auto-inhibited conformation of myosin.

Citing Articles

A FRET assay to quantitate levels of the human β-cardiac myosin interacting heads motif based on its near-atomic resolution structure.

Goluguri R, Guhathakurta P, Nandwani N, Dawood A, Yakota S, Roopnarine O bioRxiv. 2024; .

PMID: 39713291 PMC: 11661104. DOI: 10.1101/2024.12.05.626936.


Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy.

Spudich J, Nandwani N, Robert-Paganin J, Houdusse A, Ruppel K EMBO J. 2024; 43(19):4139-4155.

PMID: 39192034 PMC: 11445530. DOI: 10.1038/s44318-024-00199-x.


Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release.

Bodt S, Ge J, Ma W, Rasicci D, Desetty R, McCammon J PNAS Nexus. 2024; 3(8):pgae279.

PMID: 39108304 PMC: 11302452. DOI: 10.1093/pnasnexus/pgae279.


Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patients.

Van Den Berg M, Shi Z, Claassen W, Hooijman P, Lewis C, Andersen J Sci Transl Med. 2024; 16(758):eadg3894.

PMID: 39083588 PMC: 11586073. DOI: 10.1126/scitranslmed.adg3894.


A mutation that prevents myosin from overcoming its inhibitions.

Short B J Gen Physiol. 2024; 156(6).

PMID: 38727632 PMC: 11090048. DOI: 10.1085/jgp.202413594.


References
1.
Trivedi D, Adhikari A, Sarkar S, Ruppel K, Spudich J . Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys Rev. 2017; 10(1):27-48. PMC: 5803174. DOI: 10.1007/s12551-017-0274-6. View

2.
Wang Q, Moncman C, Winkelmann D . Mutations in the motor domain modulate myosin activity and myofibril organization. J Cell Sci. 2003; 116(Pt 20):4227-38. DOI: 10.1242/jcs.00709. View

3.
Geeves M, Coluccio L . Kinetic analyses of a truncated mammalian myosin I suggest a novel isomerization event preceding nucleotide binding. J Biol Chem. 2000; 275(28):21624-30. DOI: 10.1074/jbc.M000342200. View

4.
Lee K, Sulbaran G, Yang S, Mun J, Alamo L, Pinto A . Interacting-heads motif has been conserved as a mechanism of myosin II inhibition since before the origin of animals. Proc Natl Acad Sci U S A. 2018; 115(9):E1991-E2000. PMC: 5834683. DOI: 10.1073/pnas.1715247115. View

5.
Gunther L, Rohde J, Tang W, Walton S, Unrath W, Trivedi D . Converter domain mutations in myosin alter structural kinetics and motor function. J Biol Chem. 2018; 294(5):1554-1567. PMC: 6364761. DOI: 10.1074/jbc.RA118.006128. View